Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$32,099,214
+$737,758 QoQ
Shares Held
51,479
+26.8% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#155
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $93,187,790 across 6 Biotechnology names. REGN ranks #2 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,075 | $53,684,094 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
51,479 | $32,099,214 | |
| 3 | MRNA |
Moderna, Inc.
|
86,677 | $6,069,989 | |
| 4 | INCY |
Incyte Corp
|
7,250 | $821,860 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
3,582 | $292,183 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
13,029 | $220,450 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,099,214 | 51,479 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $31,361,456 | 40,590 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $29,124,198 | 37,732 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $39,997,075 | 71,135 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,267,950 | 19,558 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $7,516,893 | 11,852 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,326,803 | 7,478 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,092,445 | 7,698 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,957,347 | 7,571 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $7,165,738 | 7,445 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,381,149 | 8,404 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,473,299 | 9,081 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $6,848,404 | 9,531 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,532,193 | 11,601 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $9,155,708 | 12,690 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,555,104 | 16,774 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $9,972,363 | 16,870 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $14,506,183 | 20,770 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $11,619,968 | 18,400 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,613,889 | 15,886 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $10,431,851 | 18,677 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $8,492,862 | 17,950 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $6,225,837 | 12,887 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,882,728 | 10,509 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $4,936,813 | 7,916 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $3,864,327 | 7,914 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||